angiotensin ii has been researched along with Diabetes Mellitus, Type 1 in 92 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (10.87) | 18.7374 |
1990's | 22 (23.91) | 18.2507 |
2000's | 32 (34.78) | 29.6817 |
2010's | 24 (26.09) | 24.3611 |
2020's | 4 (4.35) | 2.80 |
Authors | Studies |
---|---|
Bernardi, S; Candido, R; Cortello, T; Fabris, B; Toffoli, B; Tommasi, E; Tonon, F | 1 |
Dias-Pereira, P; Duarte-Araújo, M; Esteves-Monteiro, M; Ferreira-Duarte, M; Menezes-Pinto, D; Morato, M | 1 |
Bjornstad, P; Cham, L; Cherney, DZI; Lai, V; Lovblom, LE; Lytvyn, Y; Melena, I; Orszag, A; Perkins, BA; Piani, F; Reinicke, T; Tse, J | 1 |
Keshawy, MM; Makary, S; Tawfik, MK | 1 |
Advani, A; Cherney, DZI; Fong, D; Har, R; Lai, V; Locke, A; Lytvyn, Y; Perkins, BA | 1 |
Bjornstad, P; Boulet, G; Brent, MH; Bril, V; Cham, L; Cherney, DZ; Farooqi, MA; Keenan, HA; Lai, V; Lovblom, LE; Lovshin, JA; Lytvyn, Y; Orszag, A; Paul, N; Perkins, BA; Scarr, D; Tse, J; Weisman, A | 1 |
Aziz, NM; El-Tahawy, NF; Elbassuoni, EA | 1 |
Advani, A; Bjornstad, P; Boulet, G; Brent, MH; Bril, V; Cham, L; Cherney, DZI; Farooqi, MA; Keenan, HA; Lai, V; Lovblom, LE; Lovshin, JA; Lytvyn, Y; Paul, N; Perkins, BA; Sochett, E; Tse, J; Weisman, A | 1 |
Corrêa, FM; de Oliveira, AM; Gomes, MS; Pernomian, L; Ramalho, LN; Restini, CB | 1 |
Biggi, A; Boeti, L; Cabassi, A; Cherney, DZ; Crocamo, A; Montanari, A; Musiari, L; Pelà, G | 1 |
Batlle, D; Burns, KD; Garcia-Halpin, L; Maier, C; Sowers, K; Wysocki, J; Ye, M | 1 |
Liu, X; Patel, KP; Zheng, H | 1 |
Cherney, DZ; Maahs, DM; Perkins, BA; Yang, GK | 1 |
Chen, X; Diao, TY; Gu, SS; Pan, H; Wong, MS; Zhang, FY; Zhang, Y | 1 |
Chen, Y; Gao, H; Liu, Z; Qiu, S; Shen, T; Sun, Y; Wen, X; Zhao, Y | 1 |
Calderone, A; Chabot, A; Dupuis, J; El Khoury, N; Fiset, C; Hertig, V; Jasmin, JF; Meus, MA; Nattel, S; Naud, P; Villeneuve, L | 1 |
Cosic, A; Drenjancevic, I; Falck, JR; Kibel, A; Mihaljevic, Z; Novak, S | 1 |
Abdo, S; Chan, JS; Chenier, I; Filep, JG; Ingelfinger, JR; Lo, CS; Padda, R; Shi, Y; Zhang, SL | 1 |
Coffman, TM; Dolber, PC; Fraser, MO; Gurley, SB; Jin, H; Nassar, R | 1 |
da Silva, CH; de Oliveira, AM; do Prado, AF; Gomes, MS; Moreira, JD; Moreira, RP; Pernomian, L | 2 |
Kamata, K; Kobayashi, T; Matsumoto, T; Nogami, T; Taguchi, K | 1 |
Ravid, M | 1 |
Chai, Q; He, T; Katusic, ZS; Lee, HC; Lu, T; Wang, RX; Wang, XL; Zhang, DM | 1 |
Bradley, TJ; Cherney, DZ; Dekker, MG; Lai, V; Miller, JA; Reich, HN; Scholey, JW; Sochett, EB; Zinman, B | 1 |
Glassock, RJ | 1 |
Chen, J; Chopp, M; Cui, X; Cui, Y; Liu, X; Lu, M; Roberts, C; Shehadah, A; Yan, T; Ye, X; Zacharek, A | 1 |
Bradley, TJ; Cherney, DZ; Lai, V; Reich, HN; Scholey, JW; Slorach, C; Zinman, B | 1 |
Akhtar, S; Benter, IF; Dhaunsi, GS; Makki, BM; Qabazard, BA; Yousif, MH | 1 |
Fan, ZD; Gan, XB; Gao, XY; Xiong, XQ; Zhang, L; Zhu, GQ | 1 |
Devonald, MA; Karet, FE | 1 |
Abdi, R; Dong, VM; Lee, CJ; Ntoso, KA | 1 |
Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L | 1 |
Camussi, G; Deferrari, G; Doublier, S; Lupia, E; Ruotsalainen, V; Salvidio, G; Verzola, D | 1 |
Blumenstein, M; Dietrich, W | 1 |
Chudek, J; Kokot, F; Wiecek, A | 1 |
Curtis, JR; Miller, JA; Sochett, EB | 1 |
Mohanram, A; Toto, RD | 1 |
Bramlage, P; Dikow, R; Kirch, W; Lehnert, H; Pittrow, D; Ritz, E; Wittchen, HU | 1 |
Agarwal, A; Fisher, ND; Hollenberg, NK; Laffel, LM; Lansang, MC; Price, DA; Stevanovic, R; Williams, GH | 1 |
Liu, XF; Shimoni, Y | 1 |
Hiilesmaa, VK; Immonen, IJ; Kaaja, RJ; Loukovaara, S; Nicholls, G; Yandle, TG | 1 |
Cooper, ME; Thomas, MC; Tikellis, C | 1 |
Allard, SE; Browne, DL; Cummings, MH; Meeking, DR; Munday, JL; Shaw, KM | 1 |
Boix, E; Moreno, O; Picó, A; Zapater, P | 1 |
Barit, D; Cooper, ME; Giunti, S | 1 |
Arafat, HA; Chipitsyna, G; Gong, Q; Gray, CF; Haroon, Y; Kamer, E | 1 |
Adler, SG; Kato, M; Lanting, L; Li, SL; Natarajan, R; Reddy, MA; Shanmugam, N; Wang, M; Xu, ZG; Yuan, H | 1 |
Arrick, DM; Mayhan, WG; Sharpe, GM; Sun, H | 1 |
Bradley, TJ; Cherney, DZ; Dekker, MG; Hébert, RL; Miller, JA; Nasrallah, R; Scholey, JW; Slorach, C; Sochett, EB | 1 |
Drury, PL; Ferriss, JB; Smith, GM | 1 |
Rösen, P; Rösen, R; Rump, AF | 1 |
Eadington, DW; Frier, BM; Swainson, CP | 1 |
Burden, AC; Hearnshaw, JR; McNally, PG; Rimmer, T; Thurston, H; Watt, PA | 1 |
Beretta-Piccoli, C; Cusi, D; Elshater-Zanetti, F; Shaw, S; Weidmann, P | 1 |
Christensen, P; Feldt-Rasmussen, B; Jensen, T; Nørgaard, K | 1 |
Eadington, DW; Frier, BM; Johnston, N; Lee, MR; Samson, RR; Swainson, CP | 1 |
Bender, R; Berger, M; Dworschak, A; Mühlhauser, I; Prange, K; Sawicki, PT; Schaden, W | 1 |
Leese, GP; Vora, JP | 1 |
Bensaoula, T; Eichberg, J; Ottlecz, A; Peterson, RG | 1 |
Adèr, HJ; Donker, AJ; Gans, RO; Spooren, PF; Vermes, I | 1 |
Stoschitzky, K | 1 |
Williams, B | 1 |
Brocco, S; Bruttomesso, D; Del Prato, S; Girardi, C; Jori, E; Mazzon, C; Pianta, A; Semplicini, A; Tiengo, A; Trevisan, R; Vedovato, M | 1 |
Debatin, KM; Haeberle, U; Heinze, E; Holl, RW; Lang, D; Pavlovic, M; Schwarz, K | 1 |
Miller, JA | 1 |
Małyszko, J; Myśliwiec, M; Zbroch, E | 1 |
Brockman, D; Eis, A; Kossenjans, W; Myatt, L; Sahay, R | 1 |
Burns, KD | 1 |
de La Sierra, A; Ruilope, LM | 1 |
Abe, A; Hosoya, T; Imasawa, T; Kuriyama, S; Tomonari, H | 1 |
Brands, MW; Fitzgerald, SM | 1 |
Shimoni, Y | 1 |
Beevers, DG; Lip, GY | 1 |
Gordon, MS; Hollenberg, NK; Price, DA | 1 |
Arnqvist, HJ; Bojestig, M; Karlberg, BE; Ludvigsson, J; Nystrom, FH | 1 |
Boner, G; Erman, A; van Dijk, DJ | 1 |
Frier, BM; Hepburn, DA; Patrick, AW; Swainson, CP | 1 |
Benjamin, N; Doktor, HS; Halkin, A; Ritter, JM; Todd, SD; Viberti, G | 1 |
Eadington, DW; Frier, BM; Semple, PF; Swainson, CP | 1 |
Ben, GP; Carraro, A; Cipollina, MG; Duner, E; Fioretto, P; Giorato, C; Mollo, F; Morocutti, A; Sacerdoti, D; Sambataro, M | 1 |
Bergström, B; Bramnert, M; Lilja, B; Manhem, P; Sundkvist, G | 1 |
Aurell, M; Björck, S; Bresäter, LE; Herlitz, H; Welin, L; Wikstrand, J | 1 |
Hasslacher, C; Mann, JF; Mürtz, H; Ritz, E; Sis, J; Usadel, KH | 1 |
Giese, J; Hommel, E; Mathiesen, ER; Nielsen, MD; Parving, HH; Schütten, HJ | 1 |
Kaysen, GA; Krolewski, AS; Meyer, TW; Noth, RH; Schambelan, M | 1 |
Donnelly, T; Espiner, EA; Hamilton, EJ; Ikram, H; Nicholls, MG; Richards, AM | 1 |
Connell, JM; Ding, YA; Fisher, BM; Frier, BM; Semple, PF | 1 |
Christiansen, JS; Damkjaer, M; Giese, J; Parving, HH | 1 |
Ramos, OL | 1 |
Bent-Hansen, L; Christensen, NJ; Deckert, T; Feldt-Rasmussen, B; Giese, J; Mathiesen, ER; Nielsen, MD | 1 |
Christlieb, AR | 1 |
16 review(s) available for angiotensin ii and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Meta-Analysis as Topic; Renin-Angiotensin System | 2009 |
Uremia (end-stage renal disease): how cost-effective are preventive strategies?
Topics: Angiotensin II; Antihypertensive Agents; Cost-Benefit Analysis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Mass Screening; Proteinuria | 2010 |
Targeting the renin-angiotensin system in patients with renal disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Contraindications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypertension; Kidney Diseases; Proteinuria; Risk Factors; Vasoconstrictor Agents | 2002 |
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil | 2002 |
Role of angiotensin II in the progression of diabetic nephropathy-therapeutic implications.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Progression; Female; Humans; Male; Prognosis; Receptors, Angiotensin; Renin-Angiotensin System; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2003 |
Outcome studies in diabetic nephropathy.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypertension, Renal; Irbesartan; Kidney Failure, Chronic; Male; Outcome Assessment, Health Care; Proteinuria; Renin-Angiotensin System; Risk Factors; Smoking; Tetrazoles | 2003 |
Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibrosis; Humans; Hyperglycemia; Hypoglycemia; Islets of Langerhans; Pancreas; Peptidyl-Dipeptidase A; PPAR gamma; Receptors, Angiotensin; Renin; Renin-Angiotensin System | 2006 |
Diabetic nephropathy: from mechanisms to rational therapies.
Topics: Angiotensin II; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelin-1; Glycation End Products, Advanced; Humans; Hypertension; Protein Kinase C; Urotensins | 2006 |
The management of hypertension in diabetes: with special reference to diabetic kidney disease.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Catecholamines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Glomerular Filtration Rate; Hypertension | 1996 |
[New concepts in the pathogenesis of essential hypertension].
Topics: Adult; Angiotensin II; Child; Diabetes Mellitus, Type 1; Endothelin-1; Humans; Hypertension; Nitric Oxide; Obesity; Poland; Risk Factors; Sodium, Dietary | 1999 |
Angiotensin II and its receptors in the diabetic kidney.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Bacterial Agents; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kidney; Kidney Glomerulus; Mice; Peptidyl-Dipeptidase A; Proteinuria; Rats; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin | 2000 |
Treatment of hypertension in diabetes mellitus.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypertension; Kidney Diseases; Myocardial Infarction; Placebos; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors | 2000 |
Arterial pressure control at the onset of type I diabetes: the role of nitric oxide and the renin-angiotensin system.
Topics: Angiotensin II; Animals; Blood Pressure; Cardiovascular System; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Humans; Hypertension; Kidney; Nitric Oxide; Renin-Angiotensin System | 2001 |
The protective effect of blocking angiotensin in both type I and type II diabetics with nephropathy.
Topics: Aged; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Irbesartan; Losartan; Male; Middle Aged; Primary Prevention; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Tetrazoles; Treatment Outcome | 2001 |
Diabetic nephropathy: hemodynamic basis and implications for disease management.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fatty Acids, Unsaturated; Hemodynamics; Humans; Hypertension; Kidney Failure, Chronic; Kidney Glomerulus; Proteinuria; Renin-Angiotensin System | 1989 |
Diabetes and hypertensive vascular disease. Mechanisms and treatment.
Topics: Alloxan; Angiotensin II; Animals; Blood Volume; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Hypertension; Hypertension, Renal; Juxtaglomerular Apparatus; Nephrosclerosis; Rats; Renin; Sympathetic Nervous System | 1973 |
10 trial(s) available for angiotensin ii and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
Topics: Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Case-Control Studies; Diabetes Mellitus, Type 1; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; Losartan; Male; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renal Circulation; Renin-Angiotensin System; Signal Transduction; Up-Regulation; Young Adult | 2013 |
Systemic hemodynamic function in humans with type 1 diabetes treated with protein kinase Cβ inhibition and renin-angiotensin system blockade: a pilot study.
Topics: Adult; Angiotensin II; Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 1; Enzyme Inhibitors; Female; Glucose Clamp Technique; Hemodynamics; Humans; Hyperglycemia; Indoles; Infusions, Intravenous; Male; Maleimides; Pilot Projects; Protein Kinase C; Protein Kinase C beta; Renin-Angiotensin System | 2012 |
Angiotensin II does not affect endothelial tone in Type 1 diabetes-results of a double-blind placebo controlled trial.
Topics: Acetylcholine; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Indomethacin; Infusions, Intra-Arterial; Irbesartan; Male; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Tetrazoles; Vasoconstriction; Vasodilator Agents | 2006 |
Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.
Topics: Adolescent; Adult; Angiotensin II; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Humans; Male; Prostaglandins; Proteinuria; Pyrazoles; Renal Circulation; Sex Characteristics; Sulfonamides; Vasoconstrictor Agents; Vasodilation | 2008 |
Renal tubular responses to low-dose infusion of angiotensin II in type 1 diabetes mellitus; relation to chronic glycaemic control.
Topics: Adult; Angiotensin II; Blood Glucose; Diabetes Mellitus, Type 1; Glomerular Filtration Rate; Hemodynamics; Humans; Infusions, Intravenous; Kidney Tubules; Male; Renal Plasma Flow, Effective; Sodium | 1994 |
A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
Topics: Adult; Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Isradipine; Lipoproteins; Male; Middle Aged; Potassium; Sodium | 1993 |
Urinary dopamine response to angiotensin II is not abnormal in type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Angiotensin II; Diabetes Mellitus, Type 1; Dopamine; Humans; Infusions, Intravenous; Insulin; Lithium; Male; Natriuresis; Potassium | 1993 |
Effects of dietary sodium on blood pressure in IDDM patients with nephropathy.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diastole; Diet, Sodium-Restricted; Energy Intake; Epinephrine; Erythrocyte Volume; Hematocrit; Humans; Middle Aged; Norepinephrine; Patient Education as Topic; Peptidyl-Dipeptidase A; Placebos; Potassium; Renin; Renin-Angiotensin System; Sodium; Sodium, Dietary; Statistics, Nonparametric; Systole | 1996 |
Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Humans; Hyperglycemia; Kidney; Losartan; Male; Natriuresis; Renal Circulation; Renin-Angiotensin System; Vascular Resistance | 1999 |
Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Enalapril; Humans; Middle Aged; Peptidyl-Dipeptidase A; Renin; Time Factors | 2000 |
66 other study(ies) available for angiotensin ii and Diabetes Mellitus, Type 1
Article | Year |
---|---|
Type 1 diabetes is associated with significant changes of ACE and ACE2 expression in peripheral blood mononuclear cells.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme 2; Case-Control Studies; COVID-19; Diabetes Mellitus, Type 1; Female; Humans; Leukocytes, Mononuclear; Male; Peptidyl-Dipeptidase A; Renin-Angiotensin System; RNA, Viral; SARS-CoV-2 | 2022 |
Histomorphometry Changes and Decreased Reactivity to Angiotensin II in the Ileum and Colon of Streptozotocin-Induced Diabetic Rats.
Topics: Angiotensin II; Animals; Colon; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Ileum; Male; Rats; Rats, Wistar; Streptozocin | 2022 |
Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease.
Topics: Adult; Angiotensin II; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glycopeptides; Hemodynamics; Humans; Renin; Renin-Angiotensin System; Vascular Resistance; Vasopressins | 2021 |
Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression.
Topics: Angiopoietin-Like Protein 2; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression; Kidney; Male; NF-kappa B; Protective Agents; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptor, Angiotensin, Type 2; RNA, Messenger; Streptozocin; Toll-Like Receptor 4; Treatment Outcome; Valsartan | 2021 |
Renal and Vascular Effects of Uric Acid Lowering in Normouricemic Patients With Uncomplicated Type 1 Diabetes.
Topics: Adult; Angiotensin II; Blood Pressure; Case-Control Studies; Diabetes Mellitus, Type 1; Febuxostat; Female; Glomerular Filtration Rate; Gout Suppressants; Humans; Hyperglycemia; Interleukin-18; Linear Models; Male; Nitric Oxide; Nitroglycerin; Renal Plasma Flow, Effective; Renin-Angiotensin System; Uric Acid; Vascular Stiffness; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Young Adult | 2017 |
Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.
Topics: Aged; Angiotensin II; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glycated Hemoglobin; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Renin-Angiotensin System; Vasoconstriction | 2018 |
Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide.
Topics: Angiotensin II; Animals; Biomarkers; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enzyme Inhibitors; Islets of Langerhans; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2018 |
Renal Hemodynamic Function and RAAS Activation Over the Natural History of Type 1 Diabetes.
Topics: Adolescent; Adult; Age Factors; Aged; Angiotensin II; Canada; Cohort Studies; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glomerular Filtration Rate; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Renin-Angiotensin System; Risk Assessment; Vascular Resistance; Young Adult | 2019 |
Diabetes confers a vasoprotective role to the neurocompensatory response elicited by carotid balloon injury: consequences on contralateral carotid tone and blood flow.
Topics: Angioplasty, Balloon; Angiotensin II; Animals; Aorta; Carotid Artery Injuries; Cerebrovascular Circulation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hydrogen Peroxide; Male; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Superoxides; Vasoconstriction | 2013 |
Regulation of urinary ACE2 in diabetic mice.
Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Biomarkers; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Male; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A | 2013 |
Centrally mediated erectile dysfunction in rats with type 1 diabetes: role of angiotensin II and superoxide.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Behavior, Animal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Erectile Dysfunction; Excitatory Amino Acid Agonists; Humans; Male; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Paraventricular Hypothalamic Nucleus; Penile Erection; Penis; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Superoxides | 2013 |
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glucose Clamp Technique; Heart Rate; Humans; Hyperglycemia; Kidney; Male; Renin | 2013 |
Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.
Topics: Acid Phosphatase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Isoenzymes; Male; Mice; Mice, Inbred DBA; NF-kappa B; Osteocalcin; Osteoclasts; Random Allocation; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin; Tartrate-Resistant Acid Phosphatase; Tibia; Transforming Growth Factor beta; Up-Regulation | 2014 |
Yeast exposure in the preparation of steamed rehmannia root improving its effects on alloxan-induced diabetic rats.
Topics: 6-Ketoprostaglandin F1 alpha; Aldosterone; Alloxan; Angiotensin II; Animals; Behavior, Animal; Blood Urea Nitrogen; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fermentation; Male; Plant Extracts; Plant Roots; Potassium; Rats; Rats, Wistar; Rehmannia; Sodium; Steam; Thromboxane B2; Yeast, Dried | 2013 |
Nestin is a marker of lung remodeling secondary to myocardial infarction and type I diabetes in the rat.
Topics: Actins; Airway Remodeling; Angiotensin II; Animals; Biomarkers; Cell Differentiation; Collagen Type I; Diabetes Mellitus, Type 1; Fibroblasts; Heart Failure; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Male; MicroRNAs; Myocardial Contraction; Myocardial Infarction; Nestin; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Transforming Growth Factor beta | 2015 |
Hyperbaric oxygenation modulates vascular reactivity to angiotensin-(1-7) in diabetic rats: potential role of epoxyeicosatrienoic acids.
Topics: 8,11,14-Eicosatrienoic Acid; Amides; Angiotensin I; Angiotensin II; Animals; Aorta, Thoracic; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Enzyme Induction; Enzyme Inhibitors; Hyperbaric Oxygenation; Male; Oxidative Stress; Peptide Fragments; Rats, Sprague-Dawley; Steroid 16-alpha-Hydroxylase; Vascular Resistance; Vasoconstriction; Vasodilation; Vasodilator Agents | 2015 |
Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Glucose; Blotting, Western; Diabetes Mellitus, Type 1; Fibrosis; Gene Expression Regulation; Histological Techniques; Hypertension; Immunohistochemistry; Injections, Subcutaneous; Kidney Diseases; Kidney Tubules, Proximal; Male; Mice; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled | 2015 |
The effects of Ins2(Akita) diabetes and chronic angiotensin II infusion on cystometric properties in mice.
Topics: Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Male; Mice; Urinary Bladder; Urinary Bladder Diseases; Urination | 2015 |
Acute restraint stress increases carotid reactivity in type-I diabetic rats by enhancing Nox4/NADPH oxidase functionality.
Topics: Acetylcholine; Angiotensin II; Animals; Carotid Arteries; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Male; NADPH Oxidase 4; NADPH Oxidases; Organ Culture Techniques; Rats; Rats, Wistar; Restraint, Physical; Stress, Psychological; Vasoconstriction | 2015 |
Enhanced nitric oxide generation from nitric oxide synthases as the cause of increased peroxynitrite formation during acute restraint stress: Effects on carotid responsiveness to angiotensinergic stimuli in type-1 diabetic rats.
Topics: Angiotensin II; Animals; Behavior, Animal; Carotid Arteries; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelial Cells; Enzyme Activation; Gene Expression Regulation, Enzymologic; Male; Nitric Oxide; Nitric Oxide Synthase; Peroxynitrous Acid; Phenylephrine; Phosphorylation; Rats; Rats, Wistar; Restraint, Physical; Stress, Psychological; Vasoconstriction | 2016 |
Diabetic state, high plasma insulin and angiotensin II combine to augment endothelin-1-induced vasoconstriction via ETA receptors and ERK.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelin A Receptor Antagonists; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Hypertension; Insulin; Losartan; Male; Mitogen-Activated Protein Kinases; Rats; Rats, Wistar; Receptor, Endothelin A; Streptozocin; Vasoconstriction | 2008 |
Regulation of coronary arterial BK channels by caveolae-mediated angiotensin II signaling in diabetes mellitus.
Topics: Angiotensin II; Animals; Caveolae; Caveolin 1; Coronary Vessels; CSK Tyrosine-Protein Kinase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gq-G11; Large-Conductance Calcium-Activated Potassium Channels; Male; Membrane Potentials; Mice; Mice, Knockout; Muscle, Smooth, Vascular; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Oxidation-Reduction; Patch-Clamp Techniques; Phosphorylation; Potassium; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; src-Family Kinases; Time Factors; Vasoconstriction | 2010 |
Age is a determinant of acute hemodynamic responses to hyperglycemia and angiotensin II in humans with uncomplicated type 1 diabetes mellitus.
Topics: Adolescent; Adult; Aging; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glucose Clamp Technique; Hemodynamics; Humans; Hyperglycemia; Kidney; Male; Polyuria; Renal Plasma Flow, Effective; Renin-Angiotensin System; Thirst; Vascular Resistance | 2010 |
Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats.
Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Blood-Brain Barrier; Cerebral Hemorrhage; Cerebrovascular Circulation; Cholesterol, HDL; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Niacin; Rats; Rats, Wistar; Vasodilator Agents | 2011 |
Characterization of Angiotensin-(1-7) effects on the cardiovascular system in an experimental model of type-1 diabetes.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Captopril; Cardiovascular System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Endothelin-1; Hyperglycemia; Kidney; Losartan; Male; NADPH Oxidases; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury | 2012 |
Involvement of enhanced cardiac sympathetic afferent reflex in sympathetic activation in early stage of diabetes.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Bradykinin; Capsaicin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diterpenes; Heart; Kidney; Lidocaine; Losartan; Male; Norepinephrine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reflex; Sympathetic Nervous System; TRPV Cation Channels | 2012 |
Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema.
Topics: Adult; Angioedema; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cough; Diabetes Mellitus, Type 1; Enalapril; Female; Humans; Losartan; Pharyngitis | 2002 |
Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Biopsy; Blotting, Western; Cells, Cultured; Cytochalasin B; Cytoskeleton; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fluorescent Antibody Technique, Indirect; Gene Expression; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Kidney; Male; Membrane Proteins; Microscopy, Fluorescence; Middle Aged; Nephrotic Syndrome; Proteins; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Tissue Distribution | 2003 |
[Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!].
Topics: Adolescent; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Kidney Failure, Chronic; Risk Factors; Smoking Cessation; Sodium Chloride Symporter Inhibitors; Time Factors | 2003 |
Relationship between diurnal blood pressure, renal hemodynamic function, and the renin-angiotensin system in type 1 diabetes.
Topics: Adolescent; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Body Mass Index; Circadian Rhythm; Diabetes Mellitus, Type 1; Enalapril; Glomerular Filtration Rate; Glucose Clamp Technique; Hemodynamics; Humans; Renal Circulation; Renin-Angiotensin System; Vascular Resistance | 2003 |
[Microalbuminuria is an early marker for increased morbidity and mortality].
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Losartan; Male; Meta-Analysis as Topic; Prevalence; Proteinuria; Renin-Angiotensin System; Risk Factors; Stroke | 2003 |
Plasma aldosterone concentration in the patient with diabetes mellitus.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Humans; Male; Middle Aged; Osmolar Concentration; Renin; Tetrazoles | 2004 |
Gender differences in ANG II levels and action on multiple K+ current modulation pathways in diabetic rats.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Action Potentials; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclic AMP-Dependent Protein Kinases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Electric Conductivity; Enzyme Inhibitors; Female; Genistein; Indoles; Male; Maleimides; Myocytes, Cardiac; Patch-Clamp Techniques; Potassium Channels; Protein Kinase C; Protein-Tyrosine Kinases; Quinapril; Rats; Rats, Sprague-Dawley; Sex Characteristics; Signal Transduction; Tetrahydroisoquinolines; Thionucleotides | 2004 |
Vasoactive mediators and retinopathy during type 1 diabetic pregnancy.
Topics: Adrenomedullin; Adult; Aldosterone; Angiotensin II; Blood Flow Velocity; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Disease Progression; Female; Glycated Hemoglobin; Humans; Natriuretic Peptides; Peptides; Pregnancy; Pregnancy in Diabetics; Renin; Renin-Angiotensin System; Retinal Vessels; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Teratogenicity with angiotensin II receptor antagonists in pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Diabetes Mellitus, Type 1; Female; Humans; Irbesartan; Kidney; Neural Tube Defects; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Tetrazoles | 2005 |
Induction of monocyte chemoattractant protein-1 expression by angiotensin II in the pancreatic islets and beta-cells.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line, Tumor; Chemokine CCL2; Diabetes Mellitus, Type 1; Gene Expression; Hyperglycemia; Imidazoles; Insulin-Secreting Cells; Insulinoma; Interleukin-1beta; Losartan; Mice; Mice, Inbred NOD; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Pancreatic Neoplasms; Promoter Regions, Genetic; Protein-Tyrosine Kinases; Pyridines; Rats; Receptor, Angiotensin, Type 1; RNA, Messenger; Vasoconstrictor Agents | 2007 |
Products of 12/15-lipoxygenase upregulate the angiotensin II receptor.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Lipid Metabolism; Mesangial Cells; Mice; Mice, Inbred C57BL; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; RNA, Small Interfering; Up-Regulation | 2008 |
Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Arterioles; Cerebral Arteries; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Superoxides; Vasodilation | 2008 |
Increased vasopressor responsiveness to angiotensin II in type 1 (insulin-dependent) diabetic patients without complications.
Topics: Adult; Angiotensin II; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Female; Humans; Male; Renin; Sodium | 1984 |
The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Cardiomyopathies; Dextrans; Diabetes Mellitus, Type 1; Diastole; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Glycated Hemoglobin; Heart; Heart Rate; In Vitro Techniques; Myocardial Contraction; Perfusion; Rats; Rats, Inbred BB; Systole; Ventricular Function, Left | 1995 |
Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus.
Topics: Acetylcholine; Adult; Angiotensin II; Arteries; Bradykinin; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitroprusside; Norepinephrine; Potassium; Vascular Resistance; Vasoconstriction | 1994 |
Acute sodium loading in patients with uncomplicated diabetes mellitus: renal and hormonal effects.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Norepinephrine; Peptides; Renin; Renin-Angiotensin System; Sodium | 1994 |
Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Imidazoles; Isoenzymes; Lipoxygenase Inhibitors; Losartan; Male; Masoprocol; Peptidyl-Dipeptidase A; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Rats, Zucker; Retina; Sodium-Potassium-Exchanging ATPase; Tetrazoles; Vasoconstrictor Agents | 1996 |
Urinary albumin excretion rate during angiotensin II infusion in microalbuminuric patients with insulin and non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged | 1997 |
Angiotensin II, VEGF, and diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Glycated Hemoglobin; Humans; Lisinopril; Research Design | 1998 |
Angiotensin II, VEGF, and diabetic retinopathy.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Endothelial Growth Factors; Humans; Lisinopril; Lymphokines; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria.
Topics: Adrenal Glands; Adult; Albuminuria; Angiotensin II; Blood Pressure; Body Weight; Diabetes Mellitus, Type 1; Diet; Diet, Sodium-Restricted; Female; Hemodynamics; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Natriuresis; Potassium; Renal Circulation; Sodium | 1998 |
Angiotensin I converting enzyme and angiotensinogen gene polymorphisms related to 24-h blood pressure in paediatric type I diabetes mellitus.
Topics: Adolescent; Angiotensin II; Blood Pressure; Child; Diabetes Mellitus, Type 1; Female; Gene Frequency; Genotype; Humans; Hypertension; Male; Peptidyl-Dipeptidase A; Polymorphism, Genetic | 1999 |
Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adult; Angiotensin II; Antihypertensive Agents; Diabetes Mellitus, Type 1; Epoprostenol; Female; Fetus; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide; Nitroglycerin; Oxidative Stress; Placenta; Pre-Eclampsia; Pregnancy; Reactive Oxygen Species; Tyrosine; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Humans; Losartan; Proteinuria | 2000 |
Inhibition of the formation or action of angiotensin II reverses attenuated K+ currents in type 1 and type 2 diabetes.
Topics: Action Potentials; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Electric Conductivity; Isoquinolines; Mutation; Potassium Channels; Quinapril; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Angiotensin, Type 2; Receptors, Cell Surface; Receptors, Leptin; Saralasin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2001 |
Blunted suppression of plasma renin activity in diabetes.
Topics: Adult; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diet, Sodium-Restricted; Feedback; Female; Humans; Hypertension; Male; Middle Aged; Reference Values; Renin | 2000 |
The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes.
Topics: Adult; Albuminuria; Aldosterone; Angiotensin II; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Male; Renin; Renin-Angiotensin System | 2000 |
Changes in renal function during acute insulin-induced hypoglycaemia in patients with type 1 diabetes.
Topics: Adult; Angiotensin II; Blood Glucose; Diabetes Mellitus, Type 1; Epinephrine; Glomerular Filtration Rate; Humans; Hypoglycemia; Insulin; Kidney; Male; Renal Circulation; Renin | 1992 |
Vascular responsiveness and cation exchange in insulin-dependent diabetes.
Topics: Adult; Angiotensin II; Biological Transport, Active; Carbachol; Cations; Diabetes Mellitus, Type 1; Female; Forearm; Humans; Hydrogen-Ion Concentration; Lithium; Male; Nitroprusside; Norepinephrine; Regional Blood Flow; Sodium; Vascular Resistance | 1991 |
Renal responses to angiotensin II infusion in early type 1 (insulin-dependent) diabetes.
Topics: Adult; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 1; Glomerular Filtration Rate; Heart Rate; Humans; Kidney; Male; Multivariate Analysis; Natriuresis; Renal Circulation; Renin-Angiotensin System | 1991 |
Impaired response to angiotensin II in type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium countertransport activity.
Topics: Adult; Albuminuria; Angiotensin II; Antiporters; Blood Pressure; Carrier Proteins; Diabetes Mellitus, Type 1; Erythrocytes; Female; Glomerular Filtration Rate; Humans; Hypertension; Indomethacin; Male; Potassium; Prostaglandins; Reference Values; Renal Circulation; Sodium; Vascular Resistance | 1991 |
The activity of the renin-angiotensin-aldosterone system before and during submaximal bicycle exercise in relation to circulatory catecholamines in patients with type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Aldosterone; Angiotensin II; Bicycling; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Epinephrine; Humans; Norepinephrine; Physical Exertion; Reference Values; Renin; Renin-Angiotensin System | 1990 |
Renal sensitivity to angiotensin II in type 1 diabetes.
Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Renal Circulation; Renin; Sodium; Vascular Resistance | 1990 |
Specific binding of angiotensin II and atrial natriuretic factor in non-nephropathic type I diabetes mellitus.
Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Binding Sites; Blood Platelets; Diabetes Mellitus, Type 1; Female; Humans; Kinetics; Male; Middle Aged | 1989 |
On the pathogenesis of arterial blood pressure elevation early in the course of diabetic nephropathy.
Topics: Adult; Aldosterone; Angiotensin I; Angiotensin II; Atrial Natriuretic Factor; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Extracellular Space; Female; Glomerular Filtration Rate; Humans; Hypertension; Male; Middle Aged; Plasma Volume; Renin; Renin-Angiotensin System | 1989 |
Blood pressure and vasoactive hormones with improved glycaemic control in patients with diabetes mellitus.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Epinephrine; Humans; Male; Monitoring, Physiologic; Norepinephrine; Renin | 1989 |
Reduced number of angiotensin II receptors on platelets in insulin-dependent diabetes.
Topics: Adult; Angiotensin II; Blood Platelets; Diabetes Mellitus, Type 1; Female; Humans; Male; Radioimmunoassay; Receptors, Angiotensin; Receptors, Cell Surface | 1986 |
The renin-angiotensin system and kidney function during initial insulin treatment in diabetic man.
Topics: Adult; Angiotensin II; Blood Glucose; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Humans; Insulin; Kidney; Male; Renin; Renin-Angiotensin System | 1988 |
Diabetes mellitus and hypertension. State of the art lecture.
Topics: Angiotensin II; Animals; Blood Pressure; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Humans; Hypertension; Hypertension, Renovascular; Kidney; Norepinephrine; Prazosin; Rats; Time Factors; Vasopressins | 1988 |
Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus.
Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Blood Pressure; Blood Volume; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Epinephrine; Female; Humans; Hypertension; Hypertension, Renal; Kidney Function Tests; Male; Middle Aged; Norepinephrine; Sodium; Sodium, Dietary; Water-Electrolyte Balance | 1987 |